Editing Project on Government Oversight (section)

=== FDA conflicts of interest investigation ===
Starting in 2011, POGO conducted an investigation into conflicts of interest of an advisory committee at the [[Food and Drug Administration]] that was reviewing the Yaz and [[Drospirenone|Yasmin]] birth control pills. POGO found that four members of the committee had ties to either the maker of the pills or the maker of a generic version, but did not announce the conflicts before endorsing the drugs.<ref>{{Cite news|url=http://www.sandiegouniontribune.com/sdut-stanford-doctor-in-birth-control-vote-had-ties-to--2012jan20-htmlstory.html|title=Stanford doctor in birth control vote had ties to pill's maker|date=2012-01-20|work=San Diego Union Tribune|access-date=2017-09-09|agency=The Center for Investigative Reporting|language=en-US}}</ref> Both Yaz and Yasmin have been linked to fatal blood clots in some users.<ref>{{Cite news|url=https://www.nytimes.com/2011/12/09/health/policy/stronger-label-urged-for-yaz-and-yasmin-contraceptives.html|title=Stronger Label Urged for Yaz and Yasmin Contraceptives|last=Belluck|first=Pam|date=2011-12-08|work=The New York Times|access-date=2017-09-09|language=en-US|issn=0362-4331}}</ref>